SightfileU.S. market data from official filings

IDEAYA BIOSCIENCES INC (IDYA)

Name: IDEAYA BIOSCIENCES INC (IDYA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001676725 · EDGAR filings · Updated 2026-07-09

IDEAYA BIOSCIENCES INC (IDYA) has reported institutional ownership of 107.8%, with 254 institutional managers holding positions valued at $3.16B per the latest 13F reporting period.

Institutional ownership

107.8%

Institutional managers

254

Reported 13F value

$3.16B

Insider activity

5 trans.

$1.65M net buying

Latest updates

2026-07-09 — Insider transaction reported (Form 4)
2026-07-07 — Notice of proposed sale filed (Form 144)
2026-06-23 — Current report (8-K) filed
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IDEAYA BIOSCIENCES INC has 254 institutional holders and institutional ownership of 107.8%.

Insider activity

Insiders reported 5 transactions (1 buys, 0 sells) across 3 reporting insiders, with a net reported value of $1.65M.

Related companies

STRUCTURE THERAPEUTICS INC (GPCR) · CORCEPT THERAPEUTICS INC (CORT) · TARSUS PHARMACEUTICALS INC (TARS) · ARCUTIS BIOTHERAPEUTICS INC (ARQT) · ACADIA HEALTHCARE COMPANY IN (ACHC) · HIMS & HERS HEALTH INC (HIMS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.